Abstract
Background Transmission of SARS-CoV-2 by children and young people in school settings has not been directly evaluated, nor the main mechanisms of transmission identified. The study set out to undertake sequential longitudinal sampling of infected children, their contacts, and the environment.
Methods Cases of COVID-19 were identified through statutory notification and matched to schools reporting cases. Cases of COVID-19 and their contacts from school and home were longitudinally sampled and tested for SARS-CoV-2. Surfaces and air in the home and school environment were also subject to longitudinal sampling and testing.
Results Onward transmission of virus to immediate classroom members who participated in the study was not detected. Evidence of more widespread transmission among children remaining in school was not identified with the exception of one unexpected cluster of three asymptomatic cases in one school. Children infected with SARS-CoV-2 in this study shed viral RNA for up to 10 days from symptom onset, with levels peaking at 5-8 days. Viral RNA was identified in the environment around children who were actively shedding virus in the home, but limited contamination was identified in schools. Variant of Concern B1.1.7 was identified in later cases studied.
Summary After 3 months, this small study has not found evidence to suggest COVID-19 is commonly transmitted by children within schools. A minority of infections may be subject to stochastic events that can lead to transmission. Further prospective and retrospective studies are required to identify factors associated with such events.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ISRCTN 13773960
Funding Statement
UKRI/Department of Health & Social Care, National Institute for Health Research (NIHR)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol was approved by the London (Chelsea) Research Ethics Committee (REC), HRA London Centre, Skipton House, London SE1 6LH (Schools Transmission Study REC reference 18/LO/0025; IRAS Reference 225006). Informed consent was obtained from all participants or parents/guardians, and assent was obtained from any participant aged under 18.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Any data not included in the manuscript are available from the corresponding author upon reasonable request
